Evidence map›Paper›PMID 27578327›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2016

Clinical Significance of TIPE2 Protein Upregulation in Non-Hodgkin's Lymphoma.

Chunyan Hao, Na Zhang, Minghong Geng, Qing Ren, Yan Li, Yan Wang, Youhai H Chen, Suxia Liu

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. TIPE Family of Proteins and Its Implications in Different Chronic Diseases.International journal of molecular sciences · 2018
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Chunyan HaoDepartment of Pathology, Shandong University School of Medicine, Jinan, Shandong, P.R. China (CH, YW)
Na ZhangDepartment of Immunology, Shandong University School of Medicine, Jinan, Shandong, P.R. China (NZ, MG, YL, SL)
Minghong GengDepartment of Immunology, Shandong University School of Medicine, Jinan, Shandong, P.R. China (NZ, MG, YL, SL)
Qing RenDepartment of Pediatrics, Liaocheng People's Hospital, Liaocheng, Shandong, P.R. China (QR)
Yan LiDepartment of Immunology, Shandong University School of Medicine, Jinan, Shandong, P.R. China (NZ, MG, YL, SL)
Yan WangDepartment of Pathology, Shandong University School of Medicine, Jinan, Shandong, P.R. China (CH, YW)
Youhai H ChenDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (YHC)
Suxia LiuDepartment of Immunology, Shandong University School of Medicine, Jinan, Shandong, P.R. China (NZ, MG, YL, SL)
Liaocheng People's Hospital · CNUniversity of Pennsylvania · USShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-Hodgkin's lymphoma (NHL), which includes diffuse large B-cell lymphoma (DLBCL) and peripheral T-cell lymphoma, is a refractory malignant tumor originated from the lymphatic system. TNFAIP8L2 (TIPE2 or tumor necrosis-alpha-induced protein-8 like 2) is a negative regulator for inflammation and an inhibitor for carcinogenesis. However, whether TIPE2 plays a role in lymphomagenesis is unknown. In this study, we determined TIPE2 expression in NHL by immunohistochemistry and investigated its clinicopathological significance in DLBCL. We found that TIPE2 expression was upregulated in both DLBCL and peripheral T-cell lymphoma. But the expression of TIPE2 in T lymphomas was weaker than that in DLBCL. Interestingly, among DLBCL, TIPE2 expression was significantly stronger in the germinal center B-cell (GCB) type than in the non-GCB type. These results suggest that the expression of TIPE2 protein could be a predictor of better prognosis for DLBCL.

Indexed as

AdultAgedAged, 80 and overFemaleHumansIntracellular Signaling Peptides and ProteinsLymphoma, Large B-Cell, DiffuseLymphoma, Non-HodgkinLymphoma, T-Cell, PeripheralMaleMiddle AgedPrognosisUp-RegulationYoung AdultIntracellular Signaling Peptides and ProteinsTNFAIP8L2 protein, humandiffuse large B-cell lymphomagerminal centernon-Hodgkin’s lymphomaTNFAIP8L2

Identifiers

PMID27578327
PMCPMC5006139
OpenAlexW2517178887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.